Arteris, Inc. (NASDAQ:AIP – Get Free Report) VP Paul L. Alpern sold 2,471 shares of Arteris stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $11.41, for a total transaction of $28,194.11. Following the transaction, the vice president now directly owns 64,930 shares of the company’s stock, valued at approximately $740,851.30. This trade represents a 3.67 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Arteris Stock Down 8.4 %
AIP stock opened at $11.25 on Wednesday. Arteris, Inc. has a 12 month low of $4.83 and a 12 month high of $12.64. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.30. The company has a market cap of $451.99 million, a price-to-earnings ratio of -11.72 and a beta of 1.17. The firm has a 50-day moving average of $9.00 and a two-hundred day moving average of $8.08.
Wall Street Analysts Forecast Growth
Separately, Rosenblatt Securities restated a “buy” rating and issued a $15.00 price objective on shares of Arteris in a research report on Wednesday, November 6th.
Hedge Funds Weigh In On Arteris
A number of institutional investors and hedge funds have recently added to or reduced their stakes in AIP. US Bancorp DE purchased a new position in shares of Arteris during the 3rd quarter worth $34,000. The Manufacturers Life Insurance Company purchased a new position in Arteris during the second quarter worth about $86,000. Algert Global LLC acquired a new position in Arteris in the 2nd quarter valued at about $115,000. MetLife Investment Management LLC boosted its holdings in Arteris by 129.1% in the 3rd quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock valued at $131,000 after purchasing an additional 9,551 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in shares of Arteris in the 3rd quarter valued at approximately $226,000. Institutional investors and hedge funds own 64.36% of the company’s stock.
Arteris Company Profile
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Read More
- Five stocks we like better than Arteris
- How Investors Can Find the Best Cheap Dividend Stocks
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- Do ETFs Pay Dividends? What You Need to Know
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- Health Care Stocks Explained: Why You Might Want to Invest
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.